Stocks and Investing
Stocks and Investing
Thu, September 1, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Emily Bodnar Initiated (VTYX) at Strong Buy and Held Target at $36 on, Sep 1st, 2022
Emily Bodnar of HC Wainwright & Co., Initiated "Ventyx Biosciences, Inc." (VTYX) at Strong Buy and Held Target at $36 on, Sep 1st, 2022.
Emily has made no other calls on VTYX in the last 4 months.
There are 3 other peers that have a rating on VTYX. Out of the 3 peers that are also analyzing VTYX, 0 agree with Emily's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Emily
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, August 17th, 2022
- Jeff Jones of "Oppenheimer" Maintained at Buy with Increased Target to $40 on, Tuesday, August 16th, 2022
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $63 on, Tuesday, August 16th, 2022
Contributing Sources